DUXAP8 and hepatocellular carcinoma: Methylated RNA immunoprecipitation assay with quantitative PCR analysis revealed a notably greater level of the m6A modification of DUXAP8 in HCC cell lines (Huh7 and SK-Hep-1) than in normal hepatocyte lines.